1. Home
  2. KNRX vs KRRO Comparison

KNRX vs KRRO Comparison

Compare KNRX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.98

Market Cap

49.9M

Sector

Technology

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$7.02

Market Cap

58.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNRX
KRRO
Founded
2009
2014
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
58.6M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
KNRX
KRRO
Price
$1.98
$7.02
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$74.17
AVG Volume (30 Days)
29.5K
1.1M
Earning Date
06-12-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,820,365.00
$7,371,000.00
Revenue This Year
N/A
$144.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.00
N/A
52 Week Low
$1.25
$5.20
52 Week High
$4.00
$55.89

Technical Indicators

Market Signals
Indicator
KNRX
KRRO
Relative Strength Index (RSI) N/A 27.15
Support Level N/A $5.20
Resistance Level N/A $6.59
Average True Range (ATR) 0.00 0.51
MACD 0.00 0.75
Stochastic Oscillator 0.00 89.19

Price Performance

Historical Comparison
KNRX
KRRO

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: